Cargando...
Antiviral treatment selection for SARS-CoV-2 pneumonia
INTRODUCTION: Therapy of coronavirus disease 2019 (COVID-19) involves evolving algorithms that include drugs aimed at reducing disease progression by counteracting two different, but intertwined processes: (i) the damage caused by the virus (with antivirals); (ii) the damage caused by a dysregulated...
Guardado en:
| Publicado en: | Expert Rev Respir Med |
|---|---|
| Autores principales: | , , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Taylor & Francis
2021
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8146295/ https://ncbi.nlm.nih.gov/pubmed/33962524 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/17476348.2021.1927719 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|